DRD2 and schizophrenia: Further, it was observed that hyperactivity of dopamine D2 receptor neurotransmission in subcortical and limbic brain regions contributed to the positive symptoms of schizophrenia, whereas negative and cognitive symptoms of the disorder were attributed to the dopamine D1 receptor-mediated neurotransmission hypofunction in the prefrontal cortex [168,169].